CNBX PHARMACEUTICALS INC. Interest Expense, Borrowings
CNBX PHARMACEUTICALS INC. (CNBX) reported Interest Expense, Borrowings of $39.82 thousand for the 12-month period ending 2025-08-31, per its 10-K filed 2025-12-01.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseBorrowings · last filed 2025-12-01
- CNBX PHARMACEUTICALS INC. interest expense, borrowings for fiscal 2025 was $39.82K, a 106.12% increase from fiscal 2024.
- CNBX PHARMACEUTICALS INC. interest expense, borrowings for fiscal 2024 was $19.32K, a 1545.49% increase from fiscal 2023.
- CNBX PHARMACEUTICALS INC. interest expense, borrowings for fiscal 2023 was $1.17K, a 7.78% decline from fiscal 2022.
- CNBX PHARMACEUTICALS INC. interest expense, borrowings for fiscal 2022 was $1.27K, a 46.76% decline from fiscal 2021.
| Period end | Interest Expense, Borrowings 12 month | Interest Expense, Borrowings 12 month as first filed |
|---|---|---|
| 2025-08-31 | $39.82K 10-K · filed 2025-12-01 | |
| 2024-08-31 | $19.32K 10-K · filed 2025-12-01 | |
| 2023-08-31 | $1.17K 10-K · filed 2023-11-30 | |
| 2022-08-31 | $1.27K 10-K · filed 2023-11-30 | |
| 2021-08-31 | $2.39K 10-K · filed 2022-11-30 | |
| 2020-08-31 | $8.13K 10-K · filed 2021-11-29 | $8.13K 10-K · filed 2020-11-04 |
| 2019-08-31 | $18.35K 10-K · filed 2020-11-04 |